Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28419865 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL28482698 | 0.98 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL4369287 | 0.86 | ALDH1A1 (0.41) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL6911632 | 0.81 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL11861636 | 0.76 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL28359120 | 0.75 | TSHR (0.39) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL28362812 | 0.75 | TSHR (0.39) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL1071671 | 0.74 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL65693 | 0.72 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL6243102 | 0.71 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110028412-B | Perfluoro-substituted micromolecule end group diol and preparation method and application thereof | 南京信息工程大学 | 2021-11-30 | — | — | CN | disclosed |
| US-20060235193-A1 | Biocompatible materials and probes | YALPANI MANSSUR | 2006-10-19 | — | — | US | disclosed |
| US-7090829-B2 | Antitumor agnets; anticancer agents; antidiabetic agents | CARBOMER, INC. (US) | 2006-08-15 | — | — | US | disclosed |
| US-7030208-B2 | Biocompatible materials and probes | CARBOMER, INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-20030199687-A1 | Biocompatible materials and probes | CARBOMER, INC. | 2003-10-23 | — | — | US | disclosed |
| WO-2003087165-A2 | BIOCOMPATIBLE MATERIALS AND PROBES | CARBOMER, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-2003086474-A2 | FLUORINATED OR PARAMAGNETIC ALGINATE POLYMER, ANNEXIN PARAMAGNETIC CONJUGATE, AND THEIR USE AS CONTRASTING AGENT IN MRI | CARBOMER, INC (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030198599-A1 | Novel imaging probes | CARBOMER, INC. | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198599-A1 | Novel imaging probes | MPI, MIA3, PITPNB | ALDH1A1 3450/4885TSHR 3650/4885MAPK1 3945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.